MARKET

EOLS

EOLS

Evolus
NASDAQ
7.59
+0.18
+2.43%
After Hours: 7.57 -0.02 -0.29% 19:34 08/07 EDT
OPEN
7.28
PREV CLOSE
7.41
HIGH
7.80
LOW
7.21
VOLUME
1.63M
TURNOVER
--
52 WEEK HIGH
9.35
52 WEEK LOW
3.860
MARKET CAP
501.32M
P/E (TTM)
-11.3216
1D
5D
1M
3M
1Y
5Y
1D
Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), MannKind (MNKD) and Evolus (EOLS)
TipRanks · 2d ago
Evolus: Buy Rating Reiterated on Strong Execution, Raised Guidance and Unchanged $13 Price Target
TipRanks · 2d ago
Mizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS)
TipRanks · 2d ago
Evolus Inc. Earnings Call Signals Confident Growth
TipRanks · 2d ago
Evolus Q2 EPS $(0.12), Sales $84.084M Beat $81.603M Estimate
Benzinga · 2d ago
Press Release: Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
Dow Jones · 2d ago
Here are the major earnings after the close Wednesday
Seeking Alpha · 3d ago
Evolus Expands Estyme Aesthetic Portfolio into New Markets
TipRanks · 4d ago
More
About EOLS
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.